SMYRNA TECHNOLOGY LIMITED

Company number 13133272 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

SMYRNA TECHNOLOGY LIMITED - Analysis Report

Company Number: 13133272

Analysis Date: 2025-07-29 19:24 UTC

Financial Health Assessment: Smyrna Technology Limited


1. Financial Health Score: B

Explanation:
Smyrna Technology Limited demonstrates a modest but positive financial position with growing net assets and working capital. The company is relatively young (incorporated 2021) and maintains positive net current assets, which suggests a stable liquidity position. However, overall asset size and equity remain low, reflecting its micro-sized scale and limited capital base, which constrains resilience against financial shocks. The absence of cash at the latest year-end is a mild concern, though not critical given the company's small scale and positive debtor balances.


2. Key Vital Signs:

Metric 2024 Value Interpretation
Net Current Assets £471 Positive net working capital indicates the company can cover short-term liabilities—a healthy cash flow symptom.
Net Assets (Equity) £471 Small but positive net worth indicates the company is solvent but has limited financial buffer.
Current Assets £5,241 Composed entirely of debtors; no cash on hand as of 2024 year-end, indicating potential cash flow timing issues.
Current Liabilities £4,770 Near parity with current assets, implying tight liquidity but manageable obligations.
Share Capital £100 Minimal equity investment reflects the company's micro status and early development phase.
Profit & Loss Reserves £371 Accumulated retained earnings growing over time, showing some profitability or capital contribution.
Debtors £5,241 High debtor balance relative to cash suggests revenue is tied up in receivables—potential risk if collection is delayed.
Cash at Bank £0 Lack of immediate cash "on hand" may limit the ability to meet urgent cash needs.
Employee Count 1 Very small operational scale, likely owner-managed, limiting operational leverage.

3. Diagnosis:

  • Liquidity & Working Capital:
    The company exhibits a "stable pulse" with positive net current assets (£471), meaning it can meet short-term liabilities from current assets. However, the 2024 accounts show 0 cash at bank, with all current assets in debtors. This suggests a symptom of "cash flow congestion"—the business may face timing mismatches in converting sales into usable cash. This is common in small companies relying on credit sales or invoicing delays.

  • Solvency & Equity:
    Net assets have increased from £241 in 2021 to £471 in 2024, showing gradual equity growth and suggesting that the company is solvent and not over-leveraged. Equity consists mainly of retained earnings rather than new share capital, indicating some operational profitability or at least positive net results retained in the business.

  • Growth & Scale:
    The company remains micro-sized with very modest capital and employee count. This scale limits financial resilience but also means lower operational complexity and overheads.

  • Operational Efficiency:
    The company operates in IT consultancy and online retail activities, with turnover and profit figures not disclosed in abridged accounts. The reliance on debtors as current assets points to a need for efficient receivables management to maintain a healthy cash flow.

  • Risk Factors:

    • Dependence on one director and PSC increases governance risk.
    • No cash reserves could be a "risk symptom" if unexpected expenses arise.
    • The company is exempt from audit, which may limit external oversight.

4. Recommendations:

  1. Improve Cash Flow Management:

    • Implement stricter debtor credit controls and accelerate collection processes to convert receivables into cash more quickly.
    • Consider negotiating better payment terms with customers or offering early payment incentives.
  2. Build Cash Reserves:

    • Aim to maintain a minimum cash buffer to handle short-term obligations smoothly and avoid liquidity squeeze.
    • Explore short-term financing options if necessary to cover timing gaps.
  3. Enhance Financial Reporting:

    • Even though exempt from audit, consider a voluntary financial review or internal controls strengthening to increase transparency and early risk detection.
  4. Plan for Growth:

    • As the sole employee, consider developing scalable operational processes or outsourcing non-core tasks to free capacity for business development.
  5. Maintain Compliance:

    • Ensure timely filing of accounts and confirmation statements to avoid penalties and maintain good standing.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.